{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:14:24Z","timestamp":1787933664250,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1745-6215-11-97","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T18:15:50Z","timestamp":1286993750000},"source":"Crossref","is-referenced-by-count":42,"title":["Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder"],"prefix":"10.1186","volume":"11","author":[{"given":"Kamilla W","family":"Miskowiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Vinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Ehrenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte M","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Macoveanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf B","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig R","family":"Siebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars V","family":"Kessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"508_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M: A Rating Scale for Depression. Journal of Neurology Neurosurgery and Psychiatry. 1960, 23: 56-62. 10.1136\/jnnp.23.1.56.","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"508_CR2","first-page":"286","volume":"28","author":"A Rey","year":"1941","unstructured":"Rey A: Psychological examination of traumatic encephalopathy. Archieves de Psychologic. 1941, 28: 286-340. Ref Type: Generic","journal-title":"Archieves de Psychologic"},{"key":"508_CR3","volume-title":"L'examen clinique en psychologie. Paris","author":"A Rey","year":"1964","unstructured":"Rey A: L'examen clinique en psychologie. Paris. 1964"},{"key":"508_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00406-004-0460-y","volume":"254","author":"L Clark","year":"2004","unstructured":"Clark L, Goodwin GM: State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2004, 254: 61-68. 10.1007\/s00406-004-0460-y.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"508_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1399-5618.2008.00640.x","volume":"10","author":"S Dittmann","year":"2008","unstructured":"Dittmann S, Hennig-Fast K, Gerber S, Seemuller F, Riedel M, Severus W: Cognitive functioning in euthymic bipolar I and bipolar II patients. Bipolar Disorders. 2008, 10: 877-887. 10.1111\/j.1399-5618.2008.00640.x.","journal-title":"Bipolar Disorders"},{"key":"508_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1017\/S0033291798006862","volume":"28","author":"LV Kessing","year":"1998","unstructured":"Kessing LV: Cognitive impairment in the euthymic phase of affective disorder. Psychol Med. 1998, 28: 1027-1038. 10.1017\/S0033291798006862.","journal-title":"Psychol Med"},{"key":"508_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000012361","volume":"69","author":"A Martinez-Aran","year":"2000","unstructured":"Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Gasto C: Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom. 2000, 69: 2-18. 10.1159\/000012361.","journal-title":"Psychother Psychosom"},{"key":"508_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1399-5618.2004.00111.x","volume":"6","author":"A Martinez-Aran","year":"2004","unstructured":"Martinez-Aran A, Vieta E, Colom F, Torrent C, Sanchez-Moreno J, Reinares M: Cognitive impairment in euthymic bioplar patients: implications for clinical and functional outcome. Bipolar Disorders. 2004, 6: 224-232. 10.1111\/j.1399-5618.2004.00111.x.","journal-title":"Bipolar Disorders"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-1781(01)00242-6","volume":"102","author":"JK Zubieta","year":"2001","unstructured":"Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ: Cognitive function in euthymic Bipolar I Disorder. Psychiatry Research. 2001, 102: 9-20. 10.1016\/S0165-1781(01)00242-6.","journal-title":"Psychiatry Research"},{"key":"508_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11920-004-0010-3","volume":"6","author":"SR Chamberlain","year":"2004","unstructured":"Chamberlain SR, Sahakian BJ: Cognition in mania and depression: psychological models and clinical implications. Curr Psychiatry Rep. 2004, 6: 451-458. 10.1007\/s11920-004-0010-3.","journal-title":"Curr Psychiatry Rep"},{"key":"508_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-5618.2009.00665.x","volume":"11","author":"AP Wingo","year":"2009","unstructured":"Wingo AP, Harvey PD, Baldessarini RJ: Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disorders. 2009, 11: 113-125. 10.1111\/j.1399-5618.2009.00665.x.","journal-title":"Bipolar Disorders"},{"key":"508_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ: New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006, 7: 137-151. 10.1038\/nrn1846.","journal-title":"Nat Rev Neurosci"},{"key":"508_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/FBP.0b013e3282df3cde","volume":"18","author":"BN Frey","year":"2007","unstructured":"Frey BN, Andreazza AC, Nery FG, Martins MR, Quevedo J, Soares JC: The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol. 2007, 18: 419-430. 10.1097\/FBP.0b013e3282df3cde.","journal-title":"Behav Pharmacol"},{"key":"508_CR14","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/sj.mp.4000811","volume":"5","author":"HK Manji","year":"2000","unstructured":"Manji HK, Moore GJ, Rajkowska G, Chen G: Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 2000, 5: 578-593. 10.1038\/sj.mp.4000811.","journal-title":"Mol Psychiatry"},{"key":"508_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003, 301: 805-809. 10.1126\/science.1083328.","journal-title":"Science"},{"key":"508_CR16","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","volume":"22","author":"Y Shirayama","year":"2002","unstructured":"Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS: Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002, 22: 3251-3261.","journal-title":"J Neurosci"},{"key":"508_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrn1687","volume":"6","author":"M Brines","year":"2005","unstructured":"Brines M, Cerami A: Emerging biological roles for erythropoietin in the nervous system. Nature Reviews Neuroscience. 2005, 6: 484-494. 10.1038\/nrn1687.","journal-title":"Nature Reviews Neuroscience"},{"key":"508_CR18","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","volume":"97","author":"ML Brines","year":"2000","unstructured":"Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA. 2000, 97: 10526-10531. 10.1073\/pnas.97.19.10526.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"508_CR19","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","volume":"11","author":"MB Sattler","year":"2004","unstructured":"Sattler MB, Merkler D, Maier K, Stadelmann C, Ehrenreich H, Bahr M: Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ. 2004, 11 (Suppl 2): S181-S192. 10.1038\/sj.cdd.4401504.","journal-title":"Cell Death Differ"},{"key":"508_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.mp.4001907","volume":"12","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S: Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular Psychiatry. 2007, 12: 206-220. 10.1038\/sj.mp.4001907.","journal-title":"Molecular Psychiatry"},{"key":"508_CR21","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/brain\/awm203","volume":"130","author":"H Ehrenreich","year":"2007","unstructured":"Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 2007, 130: 2577-2588. 10.1093\/brain\/awm203.","journal-title":"Brain"},{"key":"508_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1471-4159.2005.03033.x","volume":"93","author":"B Viviani","year":"2005","unstructured":"Viviani B, Bartesaghi S, Corsini E, Villa P, Ghezzi P, Garau A: Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem. 2005, 93: 412-421. 10.1111\/j.1471-4159.2005.03033.x.","journal-title":"J Neurochem"},{"key":"508_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/01.STR.0000132196.49028.a4","volume":"35","author":"L Wang","year":"2004","unstructured":"Wang L, Zhang Z, Wang Y, Zhang R, Chopp M: Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke. 2004, 35: 1732-1737. 10.1161\/01.STR.0000132196.49028.a4.","journal-title":"Stroke"},{"key":"508_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20021067","volume":"198","author":"P Villa","year":"2003","unstructured":"Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med. 2003, 198: 971-975. 10.1084\/jem.20021067.","journal-title":"J Exp Med"},{"key":"508_CR25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1096\/fj.05-3907fje","volume":"19","author":"I Yatsiv","year":"2005","unstructured":"Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG: Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J. 2005, 19: 1701-1703.","journal-title":"FASEB J"},{"key":"508_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopsych.2007.08.020","volume":"63","author":"CHY Fu","year":"2008","unstructured":"Fu CHY, Mourao-Miranda J, Costafrecla SG, Khanna A, Marquand AF, Williams SCR: Pattern classification of sad facial processing: Toward the development of neurobiological markers in depression. Biological Psychiatry. 2008, 63: 656-662. 10.1016\/j.biopsych.2007.08.020.","journal-title":"Biological Psychiatry"},{"key":"508_CR27","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/WNR.0b013e328310425e","volume":"19","author":"AF Marquand","year":"2008","unstructured":"Marquand AF, Mourao-Miranda J, Brammer MJ, Cleare AJ, Fu CHY: Neuroanatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport. 2008, 19: 1507-1511. 10.1097\/WNR.0b013e328310425e.","journal-title":"Neuroreport"},{"key":"508_CR28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1176\/appi.ajp.161.7.1256","volume":"161","author":"CJ Harmer","year":"2004","unstructured":"Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM: Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry. 2004, 161: 1256-1263. 10.1176\/appi.ajp.161.7.1256.","journal-title":"American Journal of Psychiatry"},{"key":"508_CR29","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.biopsych.2005.10.015","volume":"59","author":"CJ Harmer","year":"2006","unstructured":"Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM: Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry. 2006, 59: 816-820. 10.1016\/j.biopsych.2005.10.015.","journal-title":"Biological Psychiatry"},{"key":"508_CR30","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1176\/appi.ajp.2009.09020149","volume":"166","author":"CJ Harmer","year":"2009","unstructured":"Harmer CJ, O'Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A: Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients. American Journal of Psychiatry. 2009, 166: 1178-1184. 10.1176\/appi.ajp.2009.09020149.","journal-title":"American Journal of Psychiatry"},{"key":"508_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1176\/appi.ajp.161.1.166","volume":"161","author":"Z Bhagwagar","year":"2004","unstructured":"Bhagwagar Z, Cowen PJ, Goodwin GM, Harmer CJ: Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. American Journal of Psychiatry. 2004, 161: 166-168. 10.1176\/appi.ajp.161.1.166.","journal-title":"American Journal of Psychiatry"},{"key":"508_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0006-3223(01)01263-X","volume":"50","author":"YI Sheline","year":"2001","unstructured":"Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA: Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biological Psychiatry. 2001, 50: 651-658. 10.1016\/S0006-3223(01)01263-X.","journal-title":"Biological Psychiatry"},{"key":"508_CR33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.biopsych.2007.01.011","volume":"62","author":"K Miskowiak","year":"2007","unstructured":"Miskowiak K, O'Sullivan U, Harmer CJ: Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action. Biol Psychiatry. 2007, 62: 1244-1250. 10.1016\/j.biopsych.2007.01.011.","journal-title":"Biol Psychiatry"},{"key":"508_CR34","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1523\/JNEUROSCI.5013-06.2007","volume":"27","author":"K Miskowiak","year":"2007","unstructured":"Miskowiak K, O'Sullivan U, Harmer CJ: Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci. 2007, 27: 2788-2792. 10.1523\/JNEUROSCI.5013-06.2007.","journal-title":"J Neurosci"},{"key":"508_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00221-007-1102-1","volume":"184","author":"K Miskowiak","year":"2008","unstructured":"Miskowiak K, Inkster B, O'Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ: Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Exp Brain Res. 2008, 184: 313-321. 10.1007\/s00221-007-1102-1.","journal-title":"Exp Brain Res"},{"key":"508_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.npp.1301439","volume":"33","author":"K Miskowiak","year":"2008","unstructured":"Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ: Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology. 2008, 33: 611-618. 10.1038\/sj.npp.1301439.","journal-title":"Neuropsychopharmacology"},{"key":"508_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.biopsych.2008.12.005","volume":"66","author":"MJ Girgenti","year":"2009","unstructured":"Girgenti MJ, Hunsberger J, Duman CH, Sathyanesan M, Terwilliger R, Newton SS: Erythropoietin Induction by Electroconvulsive Seizure, Gene Regulation, and Antidepressant-Like Behavioral Effects. Biological Psychiatry. 2009, 66: 267-274. 10.1016\/j.biopsych.2008.12.005.","journal-title":"Biological Psychiatry"},{"key":"508_CR38","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1523\/JNEUROSCI.23-17-06690.2003","volume":"23","author":"AR Hariri","year":"2003","unstructured":"Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF: Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci. 2003, 23: 6690-6694.","journal-title":"J Neurosci"},{"key":"508_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00213-009-1641-1","volume":"207","author":"KW Miskowiak","year":"2009","unstructured":"Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ: Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berl). 2009, 207: 133-142. 10.1007\/s00213-009-1641-1.","journal-title":"Psychopharmacology (Berl)"},{"key":"508_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133: 429-435. 10.1192\/bjp.133.5.429.","journal-title":"Br J Psychiatry"},{"key":"508_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571.","journal-title":"Arch Gen Psychiatry"},{"key":"508_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000201934","volume":"78","author":"M Fava","year":"2009","unstructured":"Fava M, Iosifescu DV, Pedrelli P, Baer L: Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire. Psychother Psychosom. 2009, 78: 91-97. 10.1159\/000201934.","journal-title":"Psychother Psychosom"},{"key":"508_CR43","doi-asserted-by":"crossref","unstructured":"EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990, 16: 199-208. 10.1016\/0168-8510(90)90421-9.","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"508_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archpsyc.1990.01810180089012","volume":"47","author":"JK Wing","year":"1990","unstructured":"Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R: SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry. 1990, 47: 589-593.","journal-title":"Arch Gen Psychiatry"},{"key":"508_CR45","doi-asserted-by":"publisher","first-page":"e5894","DOI":"10.1371\/journal.pone.0005894","volume":"4","author":"P Hojman","year":"2009","unstructured":"Hojman P, Brolin C, Gissel H, Brandt C, Zerahn B, Pedersen BK: Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles. PLoS One. 2009, 4: e5894-10.1371\/journal.pone.0005894.","journal-title":"PLoS One"},{"key":"508_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11892-009-0010-0","volume":"9","author":"RS McIntyre","year":"2009","unstructured":"McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor VH: Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009, 9: 51-59. 10.1007\/s11892-009-0010-0.","journal-title":"Curr Diab Rep"},{"key":"508_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1399-5618.2006.00275.x","volume":"8","author":"DJ Smith","year":"2006","unstructured":"Smith DJ, Muir WJ, Blackwood DHR: Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder. Bipolar Disorders. 2006, 8: 40-46. 10.1111\/j.1399-5618.2006.00275.x.","journal-title":"Bipolar Disorders"},{"key":"508_CR48","volume-title":"Pictures of facial affect","author":"P Ekman","year":"1976","unstructured":"Ekman P, Friesen WV: Pictures of facial affect. 1976, Palo Alto: Consulting Psychologists Press"},{"key":"508_CR49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/039139889401700102","volume":"17","author":"M Beccari","year":"1994","unstructured":"Beccari M: Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention. Int J Artif Organs. 1994, 17: 5-13.","journal-title":"Int J Artif Organs"},{"issue":"Suppl 2","key":"508_CR50","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1177\/089686080702702s52","volume":"27","author":"F Locatelli","year":"2007","unstructured":"Locatelli F, Del VL, Pozzoni P: Pure red-cell aplasia \"epidemic\"--mystery completely revealed?. Perit Dial Int. 2007, 27 (Suppl 2): S303-S307.","journal-title":"Perit Dial Int"},{"key":"508_CR51","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/j.1537-2995.2008.01749.x","volume":"48","author":"JM McKoy","year":"2008","unstructured":"McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW: Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. 2008, 48: 1754-1762. 10.1111\/j.1537-2995.2008.01749.x.","journal-title":"Transfusion"},{"key":"508_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0140-6736(07)60194-9","volume":"369","author":"A Phrommintikul","year":"2007","unstructured":"Phrommintikul A, Haas SJ, Elsik M, Krum H: Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007, 369: 381-388. 10.1016\/S0140-6736(07)60194-9.","journal-title":"Lancet"},{"key":"508_CR53","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","volume":"40","author":"H Ehrenreich","year":"2009","unstructured":"Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K: Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009, 40: e647-e656. 10.1161\/STROKEAHA.109.564872.","journal-title":"Stroke"},{"key":"508_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","volume":"19","author":"M Fava","year":"1996","unstructured":"Fava M, Davidson KG: Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996, 19: 179-200. 10.1016\/S0193-953X(05)70283-5.","journal-title":"Psychiatr Clin North Am"},{"key":"508_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","volume":"53","author":"M Fava","year":"2003","unstructured":"Fava M: Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003, 53: 649-659. 10.1016\/S0006-3223(03)00231-2.","journal-title":"Biol Psychiatry"},{"key":"508_CR56","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1192\/bjp.bp.106.028555","volume":"190","author":"MA Posternak","year":"2007","unstructured":"Posternak MA, Zimmerman M: Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis. Br J Psychiatry. 2007, 190: 287-292. 10.1192\/bjp.bp.106.028555.","journal-title":"Br J Psychiatry"},{"key":"508_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ctrv.2004.04.005","volume":"30","author":"E Ferrario","year":"2004","unstructured":"Ferrario E, Ferrari L, Bidoli P, De CD, Del VM, De DS: Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat Rev. 2004, 30: 563-575. 10.1016\/j.ctrv.2004.04.005.","journal-title":"Cancer Treat Rev"},{"key":"508_CR58","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1031753100","volume":"100","author":"S Erbayraktar","year":"2003","unstructured":"Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M: Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA. 2003, 100: 6741-6746. 10.1073\/pnas.1031753100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"508_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2119\/2006-00042.Erbayraktar","volume":"12","author":"S Erbayraktar","year":"2006","unstructured":"Erbayraktar S, de LN, de LA, Knisely JP, Erbayraktar Z, Yilmaz O: Carbamylated erythropoietin reduces radiosurgically-induced brain injury. Mol Med. 2006, 12: 74-80. 10.2119\/2006-00042.Erbayraktar.","journal-title":"Mol Med"},{"key":"508_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1098313","volume":"305","author":"M Leist","year":"2004","unstructured":"Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004, 305: 239-242. 10.1126\/science.1098313.","journal-title":"Science"},{"key":"508_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1460-9568.2007.05635.x","volume":"26","author":"VR King","year":"2007","unstructured":"King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT: Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci. 2007, 26: 90-100. 10.1111\/j.1460-9568.2007.05635.x.","journal-title":"Eur J Neurosci"},{"key":"508_CR62","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3171\/JNS-07\/08\/0392","volume":"107","author":"A Mahmood","year":"2007","unstructured":"Mahmood A, Lu D, Qu C, Goussev A, Zhang ZG, Lu C: Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin. J Neurosurg. 2007, 107: 392-397. 10.3171\/JNS-07\/08\/0392.","journal-title":"J Neurosurg"},{"key":"508_CR63","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/sj.bjp.0707285","volume":"151","author":"Y Wang","year":"2007","unstructured":"Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL, Kapke A: Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol. 2007, 151: 1377-1384. 10.1038\/sj.bjp.0707285.","journal-title":"Br J Pharmacol"},{"key":"508_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2005.07.008","volume":"387","author":"YP Yu","year":"2005","unstructured":"Yu YP, Xu QQ, Zhang Q, Zhang WP, Zhang LH, Wei EQ: Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci Lett. 2005, 387: 5-10. 10.1016\/j.neulet.2005.07.008.","journal-title":"Neurosci Lett"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-11-97\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-97","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T20:22:03Z","timestamp":1636662123000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-11-97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-11-97","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]},"article-number":"97"}}